| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA1913982 | B | Irreversible inhibition of PAD3 assessed as residual activity at 1 mM measured after 20 hrs by colorimetric assay in presence of 2 mM benzoyl-L-arginine ethyl ester | 2 | ALA1909620 | single protein format | Scientific Literature | ||
| 2. | ALA1913986 | B | Irreversible inhibition of PAD3 assessed as residual activity at 1 mM measured after 20 hrs by colorimetric assay in presence of 10 mM benzoyl-L-arginine ethyl ester | 2 | ALA1909620 | single protein format | Scientific Literature | ||
| 3. | ALA1914037 | B | Ratio of Kinact to Ki for F-amidine to compound for PAD3 | 1 | ALA1909620 | single protein format | Scientific Literature | ||
| 4. | ALA1914014 | B | Irreversible inhibition of PAD3 assessed as hydrolysis of benzoyl-L-arginine ethyl ester preincubated for 15 mins measured after 15 mins by fluorometric analysis | 4 | ALA1909620 | single protein format | Scientific Literature | ||
| 5. | ALA1914103 | B | Irreversible inhibition of PAD3 assessed as residual activity at 1 mM measured after 20 hrs by colorimetric assay | 4 | ALA1909620 | single protein format | Scientific Literature | ||
| 6. | ALA1914107 | B | Irreversible inhibition of PAD3 assessed as residual activity measured after 20 hrs by colorimetric assay | 4 | ALA1909620 | single protein format | Scientific Literature | ||
| 7. | ALA1914111 | B | Ratio of Kinact to Ki for PAD3 | 4 | ALA1909620 | single protein format | Scientific Literature | ||
| 8. | ALA1914112 | B | Ratio of Kinact to Ki for PAD4 | 4 | ALA1909620 | single protein format | Scientific Literature | ||
| 9. | ALA2212941 | B | Ratio of Kinact to Ki for PAD3 | 11 | ALA2202988 | single protein format | Scientific Literature | ||
| 10. | ALA3117924 | B | Ratio of Kinact to Ki(app) for recombinant wild-type PAD3 (unknown origin) using N-alpha-Benzoyl-L-arginine amide as substrate preincubated for 10 mins followed by substrate addition measured after 15 mins by COLDER assay | Homo sapiens | 5 | ALA3112427 | single protein format | Scientific Literature | |
| 11. | ALA3119088 | B | Irreversible inhibition of recombinant wild-type PAD3 (unknown origin) using N-alpha-Benzoyl-L-arginine amide as substrate assessed as residual activity at 170-fold excess of compound after 1 hr by dialysis method | Homo sapiens | 1 | ALA3112427 | single protein format | Scientific Literature | |
| 12. | ALA3119093 | B | Inhibition of recombinant wild-type PAD3 (unknown origin) using N-alpha-Benzoyl-L-arginine amide as substrate preincubated for 15 mins followed by substrate addition measured after 15 mins by COLDER assay | Homo sapiens | 6 | ALA3112427 | single protein format | Scientific Literature | |
| 13. | ALA3119097 | B | Inhibition of recombinant wild-type PAD3 (unknown origin) using N-alpha-Benzoyl-L-arginine amide as substrate assessed as residual activity at 10 uM preincubated for 15 mins followed by substrate addition measured after 15 mins by COLDER assay relative to control | Homo sapiens | 32 | ALA3112427 | single protein format | Scientific Literature | |
| 14. | ALA3227810 | B | Competitive reversible inhibition of human recombinant PAD3 expressed in HEK293T cells assessed as rate of citrullination of BAEE at 10 to 100 uM by by Michaelis-Menten equation analysis using colorimetry | Homo sapiens | 1 | ALA3217473 | cell-based format | Scientific Literature | |
| 15. | ALA3227811 | B | Inhibition of human recombinant PAD3 expressed in HEK293T cells assessed as conversion of BAEE to sodium benzoyl-L-citrulline at 10 nM to 100 uM by colorimetric analysis | Homo sapiens | 1 | ALA3217473 | cell-based format | Scientific Literature | |
| 16. | ALA3227812 | B | Inhibition of human recombinant PAD3 expressed in HEK293T cells assessed as conversion of BAEE to sodium benzoyl-L-citrulline at 100 uM by colorimetric analysis | Homo sapiens | 1 | ALA3217473 | cell-based format | Scientific Literature | |
| 17. | ALA3227813 | B | Inhibition of human recombinant PAD3 expressed in HEK293T cells assessed as conversion of BAEE to sodium benzoyl-L-citrulline up to 1 mM by colorimetric analysis | Homo sapiens | 1 | ALA3217473 | cell-based format | Scientific Literature | |
| 18. | ALA4178565 | B | Ratio of Kinact to Ki for recombinant His6-tagged PAD3 (unknown origin) preincubated for 10 mins followed by BAA substrate addition measured after 15 mins by COLDER assay | Homo sapiens | 4 | ALA4177546 | single protein format | Scientific Literature | |
| 19. | ALA4269521 | B | Inhibition of PAD3 (unknown origin) assessed as ratio of Kinact to Ki preincubated for 2.5 to 30 mins followed by BAEE addition measured after 15 mins by spectrophotometric method | Homo sapiens | 8 | ALA4266007 | single protein format | Scientific Literature | |
| 20. | ALA4269527 | B | Inhibition of PAD3 (unknown origin) assessed as ratio of Kinact to Ki | Homo sapiens | 2 | ALA4266007 | single protein format | Scientific Literature |
The page will load shortly, Thanks for your patience!